Becker's Healthcare November 10, 2021
Hannah Mitchell

The COVID-19 pandemic has accelerated the adoption of digital health for about 20 months, but the FDA’s health IT agenda has remained largely untouched, Politico reported Nov. 10.

Five things to know:

  1. The FDA is facing several questions on the future of medical software and how this technology plays a role in telehealth and clinical decision-making moving forward, Politico reported.
  2. At the start of the pandemic, the FDA relaxed regulations on products that helped deliver virtual care. Yet once the public health emergency comes to an end, there isn’t a clear path as to what happens with these technologies, according to the report.
  3. The health IT industry is also looking for signs from the FDA on how...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Health IT, Technology
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA approves Merck drug for rare lung disorder
Neuronetics wins FDA clearance for device to treat adolescents with depression
FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval

Share This Article